<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article-commentary" dtd-version="1.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="issn">1043-3155</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol Briefs</journal-id>
<journal-id journal-id-type="pmc">pedneurbriefs</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr Neurol Briefs</journal-id>
<journal-title-group>
<journal-title>Pediatric Neurology Briefs</journal-title>
<abbrev-journal-title>Pediatr Neurol Briefs</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2166-6482</issn>
<issn pub-type="ppub">1043-3155</issn>
<issn-l>2166-3155</issn-l>
<publisher>
<publisher-name>Pediatric Neurology Briefs Publishers</publisher-name>
<publisher-loc>Chicago, IL, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PNB-2-22-b</article-id>
<article-id pub-id-type="doi">10.15844/pedneurbriefs-2-3-11</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Degenerative and Metabolic Disorders</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v2">
<subject>Neurology</subject>
<subject>Pediatrics</subject>
<subject>Nervous System Diseases</subject>
<subject>Child Development</subject>
<subject>Brain Diseases</subject>
<subject>Neurosurgery</subject>
<subject>Child</subject>
<subject>Infant</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Infantile Refsum Disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0173-7931</contrib-id>
<name>
<surname>Millichap</surname>
<given-names>J. Gordon</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
</contrib-group>
<aff id="AF0001">
<label>1</label>Division of Neurology, Children&#x0027;s Memorial Hospital, Chicago, IL</aff>
<aff id="AF0002">
<label>2</label>Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL</aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>Correspondence: Dr. J. Gordon Millichap, E-mail: <email xlink:href="jgmillichap@northwestern.edu">jgmillichap@northwestern.edu</email>
</corresp>
</author-notes>
<pub-date date-type="pub" publication-format="print">
<month>03</month>
<year>1988</year>
</pub-date>
<pub-date date-type="pub" publication-format="electronic">
<day>01</day>
<month>08</month>
<year>2016</year>
</pub-date>
<volume>2</volume>
<issue>3</issue>
<fpage>22</fpage>
<lpage>23</lpage>
<permissions>
<copyright-statement>Copyright: &#x00A9; 1988 The Author(s)</copyright-statement>
<copyright-year>1988</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under the <uri xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</uri>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article id="R1" related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.1007/BF00442210" vol="147" page="133">
<article-title>Treatment of infantile phytanic acid storage disease: clinical, biochemical and ultrastructural findings in two children treated for 2 years</article-title>
</related-article>
<abstract abstract-type="web-summary" specific-use="electronic-only">
<p>Two patients with infantile Refsum (phytanic acid storage) disease were treated at 9 mos and 5&#x00BD; years of age with a low phytanic acid diet and the effects studied over a 2-yr period or longer in the Depts of Chemical Pathology, Neurology and Histopathology, Adelaide Children&#x0027;s Hospital, and the Dept of Neurology, Prince of Wales Children&#x0027;s Hospital, New South Wales, Australia</p>
</abstract>
<kwd-group>
<kwd>Infantile Refsum Disease</kwd>
<kwd>Self-Mutilating Behavior</kwd>
<kwd>Chronic Polyneuropathy</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Two patients with infantile Refsum (phytanic acid storage) disease were treated at 9 mos and 5&#x00BD; years of age with a low phytanic acid diet and the effects studied over a 2-yr period or longer in the Depts of Chemical Pathology, Neurology and Histopathology, Adelaide Children&#x0027;s Hospital, and the Dept of Neurology, Prince of Wales Children&#x0027;s Hospital, New South Wales, Australia. Elevated phytanic and pipecolic acid plasma levels were significantly decreased but very long chain fatty acids remained grossly abnormal after 6 wks or longer on the diet consisting of skimmed milk powder, white meats, fish, root vegetables, some fruits and supplementary vitamins. Growth, motor skills, self-mutilating behavior, intention tremor and nystagmus improved, although ataxia and hypotonia persisted in the older child who developed peripheral neuropathy with slowed motor and sensory nerve conduction velocities. Impaired visual acuity with optic atrophy and retinitis pigmentosa and sensorineural deafness persisted. Head growth continued at the original 25th and 3rd low percentiles. Electronmicroscopy of liver biopsies before and after dietary treatment showed an increase in inclusion bodies, and peroxisomes and lysosomes were present. [<xref ref-type="bibr" rid="CIT0001">1</xref>]</p>
<disp-quote>
<p>
<bold>COMMENT</bold>. Infantile Refsum syndrome is characterized by retinitis pigmentosa, sensorineural deafness, developmental delay, hepatomegaly and dysmorphic features. The older of the 2 present cases showed chronic polyneuropathy, ataxia and intention tremor, typical of the classical form of Refsum disease-heredopathia atactica polyneuritiformis. The exclusion of pytanic acid from the diet of affected adults has been successful in lowering plasma phytanic acid levels, improving peripheral nerve function and arresting the progress of visual and hearing defects.</p>
</disp-quote>
</body>
<back>
<ref-list>
<ref id="CIT0001">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robertson</surname>
<given-names>EF</given-names>
</name>
<name>
<surname>Poulos</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sharp</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Manson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wise</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Jaunzems</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Treatment of infantile phytanic acid storage disease: clinical, biochemical and ultrastructural findings in two children treated for 2 years</article-title>
<source>Eur J Pediatr</source>
<year>1988</year>
<month>Feb</month>
<volume>147</volume>
<issue>2</issue>
<fpage>133</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="doi">10.1007/BF00442210</pub-id>
<pub-id pub-id-type="pmid">2452736</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
